AMGEN Inc
NASDAQ: AMGN
$337.38
+$1.43 (+0.4%)
Closing Price on September 20, 2024
AMGN Articles
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday. Advanced Micro Devices Inc. (NYSE: AMD) raised to Neutral from Sell at...
Published:
Last Updated:
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short...
Published:
It was just on Monday that we released the 24/7 Wall St. “12 Big Dividend Hikes Coming Before The End of 2012” and we already have one of the twelve coming true. Altria Group Inc. (NYSE: MO)...
Published:
Last Updated:
Most investors have discovered that earning less than 1% per year in short-term Treasuries or even less than 2% out in the 10-year Treasury is no fun. Longer-dated Treasury bonds also are proving...
Published:
Last Updated:
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the period...
Published:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) raised to Buy at Lazard. American Tower...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday morning. Abercrombie & Fitch Co. (NYSE: ANF) cut to Neutral at Baird...
Published:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St.research calls this Friday morning. Amgen Inc. (NASDAQ: AMGN) raised to Overweight at Piper Jaffray....
Published:
Last Updated:
We have many stocks on the move in the after-hours session. Today was the largest day for S&P earnings this earnings season. Some of these volume spikes are massive. Acme Packet, Inc....
Published:
Last Updated:
Amgen Inc. (NASDAQ: AMGN) today announced financial results for the second quarter of 2012. The biotech giant’s results showed a 13% revenue gain to $4.5 billion and adjusted earnings rose 34% to...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Wednesday morning. Amgen Corp. (NASDAQ: AMGN) raised to Outperform at Credit...
Published:
Last Updated:
Thursday was D-Day for the Supreme Court decision on the Obama healthcare mandate as to its constitutionality. The long and short of it is that the mandate is constitutional as a tax after a 5-4...
Published:
Last Updated:
24/7 Wall St. loves companies which send capital back to shareholders via dividends. With all of the uncertainty in today’s markets and in the fluctuating economy, having a solid dividend policy...
Published:
Last Updated:
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
Published:
Last Updated:
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech sector this week. ...
Published:
Last Updated: